Cefixime PCD Pharma Franchise Company

Cafoli Lifecare offers a large Cefixime range of 29 formulations across tablets, dry syrup and drops, manufactured in WHO-GMP certified facilities. Distributors building a broad antibiotic portfolio can secure district-wise monopoly franchise rights across this high-demand cephalosporin with full promotional support.

What is Cefixime?

Cefixime is a third-generation oral cephalosporin antibiotic. It inhibits bacterial cell-wall synthesis and has broad activity against many Gram-negative and some Gram-positive organisms, making it a mainstay oral option for common bacterial infections. Reference: PubChem - Cefixime.

Available Forms

The Cafoli Cefixime portfolio includes Tablets (plain and with clavulanic acid, ofloxacin, azithromycin or lactic-acid bacillus), Dry Syrup and Drops for paediatric dosing, and topical Cream presentations. Contact us for current pack presentations and combinations.

Therapeutic Applications

Cefixime is prescribed for respiratory tract infections, urinary tract infections, otitis media, typhoid fever and other susceptible bacterial infections in adults and children. Prescribers include physicians, paediatricians, ENT specialists, gynaecologists and general practitioners.

Why Cefixime is a High-Potential Molecule for Distributors

Cefixime is one of the most prescribed oral antibiotics in India across every age group, and its extensive combination range - especially cefixime-clavulanate and paediatric dry syrups - lets a distributor cover almost the whole community-antibiotic market from one molecule. High everyday prescription frequency across GP, paediatric and ENT practice makes it a dependable volume driver.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Cefixime
2. MedlinePlus: Cefixime
3. WHO Essential Medicines List - cefixime